Isis Pharmaceuticals is engaged in discovering and developing novel drugs for its product pipeline and for its partners through the exploitation of its leadership position in antisense technology. The company’s pipeline consists of 25 drugs to treat a wide variety of diseases, with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis’ drugs and technology are covered by the strong and extensive protection of its patents. For more information, visit the company’s Web site at www.isispharm.com.
Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
Let us hear your thoughts below: